Houston Oncology Summit: MD Anderson’s VP of industry relations talks about partnering

blonca9
Sep 21, 2023
1 min read

Ferran Prat describes what advantages MD Anderson offers to drug developers running trials, what makes a good partner, and areas of science that interest him today.

Brought to you by:

Recent Posts

See All

As federal funding for cancer research has been jeopardized at NIH and academia, Parker Institute for Cancer Immunotherapy is one private institution ready to step up and broaden its impact

Mount Sinai has embraced AI as a drug discovery tool by launching this month its new AI Small Molecule Drug Discovery Center - Professor Avner Schlessinger tells us why

Jones Healthcare & Technology Innovation Conference: Jones Research analysts Soumit Roy and Justin Walsh share their take on biotech and comment on companies they cover

Houston Oncology Summit: MD Anderson’s VP of industry relations talks about partnering

Recent Posts

Join the BiotechTV mailing list

Follow BiotechTV

Sponsors

Sponsor Spotlight